March 30, 2007

Merck insomnia drug put to bed

Gaboxadol was designed by Lundbeck in collaboration with Merck & Co. It aimed to relax the brain through activating a certain receptor called gamma-aminobutyric acid receptor A . However, in an event both have …
Comment


From Insomnia News

March 29, 2007

Merck won’t lose sleep over drug

By STEVE MITCHELL UPI Senior Medical Correspondent WASHINGTON, March 29 — Merck ceased development of their insomnia treatment, gaboxadol, but analysts don’t think the news will significantly impact the …
Comment


From Insomnia News

Anna Nicole Smith Cause Of Death Is Average Person’s Morning Ritual?

Anna Nicole Smith may have died from what the average person has everyday - caffeine.
Comment


From Insomnia News

Caffeine the Culprit?

Here’s a theory about Anna Nicole Smith ’s various drug interactions. Apparently, the antibiotic she was taking has a deleterious effect when mixed with caffeine.
Comment


From Insomnia News

Merck Cancels Work on a New Insomnia Medication

Two weeks after the Food and Drug Administration issued safety warnings about widely used sleeping pills, the drug maker Merck canceled a venture into the shifting market for insomnia medications.
Comment


From Insomnia News

Lundbeck facility in area is imperiled

Yesterdays announcement by Merck & Co. Inc. and Danish pharmaceutical company H. Lundbeck A/S that they were scrapping an insomnia drug because of disappointing effectiveness and side effects puts in jeopardy …
Comment


From Insomnia News

Insomnia drug put to rest

Merck & Co. and its Danish partner, pharmaceutical company H. Lundbeck A/S, are putting to rest development of an insomnia drug that was in the final human testing stage after studies found safety problems, …
Comment


From Insomnia News

Merck and partner cease work on insomnia drug

TRENTON, N.J. — Merck & Co. and its Danish partner, pharmaceutical company H. Lundbeck, said Wednesday they are putting to rest the development of an insomnia drug after studies found safety problems, …
Comment


From Insomnia News

Insomnia drug put to rest, Merck says

TRENTON — Merck & Co. and its Danish partner, pharmaceutical company H. Lundbeck A/S, are putting to rest development of an insomnia drug that was in the final human testing stage after studies found safety …
Comment


From Insomnia News

Merck drug fails late-stage tests

Merck and a Danish partner yesterday ended their quest for a new medicine to treat insomnia, after a late-stage study revealed a disappointing level of effectiveness and troubling side effects.
Comment


From Insomnia News

Next Page »